AMALGAMATED BANK - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$9
-25.0%
6670.0%0.00%
Q1 2024$12
-33.3%
667
-64.4%
0.00%
Q4 2023$18
-21.7%
1,875
-9.6%
0.00%
Q3 2023$23
-85.9%
2,073
-72.9%
0.00%
-100.0%
Q2 2023$163
-51.3%
7,638
-7.8%
0.00%
-66.7%
Q1 2023$335
-18.9%
8,284
-6.7%
0.00%
-25.0%
Q4 2022$413
-99.9%
8,8810.0%0.00%0.0%
Q3 2022$461,000
+15.0%
8,881
+4.7%
0.00%0.0%
Q2 2022$401,000
-32.9%
8,482
+1.0%
0.00%
-20.0%
Q1 2022$598,000
-54.3%
8,396
-52.0%
0.01%0.0%
Q4 2021$1,308,000
+155.5%
17,496
+94.3%
0.01%
+25.0%
Q3 2021$512,000
+27.0%
9,004
-1.6%
0.00%
+33.3%
Q2 2021$403,000
+94.7%
9,153
+173.4%
0.00%
-25.0%
Q4 2019$207,000
-23.9%
3,348
+3.7%
0.00%
-33.3%
Q2 2019$272,000
+4.2%
3,228
+18.0%
0.01%0.0%
Q1 2019$261,000
-17.1%
2,736
+0.8%
0.01%
-25.0%
Q2 2018$315,0002,7140.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders